Evidence map›Paper›PMID 33656540›Full record

ArticleBlood advances2021

Early detection of treatment failure and early rescue intervention in multiple myeloma: time for new approaches.

Juan José Lahuerta, Bruno Paiva, Ana Jiménez-Ubieto, José Sánchez-Pina, María-Victoria Mateos, Joan Bladé, Jesús F San-Miguel

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Juan José LahuertaInstituto de Investigación Sanitaria Hospital 12 de Octubre, Fundación PETHEMA, CIBERONC number CB16/12/00369, Madrid, Spain.
Bruno PaivaClinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBERONC number CB16/12/00369, Pamplona, Spain.
Ana Jiménez-UbietoHospital 12 de Octubre, Madrid, Spain.
José Sánchez-PinaHospital 12 de Octubre, Madrid, Spain.
María-Victoria MateosHospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBERONC number CB16/12/00233 Salamanca, Spain; and.
Joan BladéHospital Clínic IDIBAPS, Barcelona, Spain.
Jesús F San-MiguelClinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBERONC number CB16/12/00369, Pamplona, Spain.
Navarre Institute of Health Research · ESResearch Institute Hospital 12 de Octubre · ESFundación Pethema · ESHospital Clínic de Barcelona · ESInstituto de Investigación Biomédica de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsHumansTreatment Failure

Identifiers

PMID33656540
PMCPMC7948301
OpenAlexW3135501638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.